Mechanism & research context
This research blend combines 5 mg of BPC-157 and 5 mg of thymosin β4 acetate (TB-500) in a single lyophilized vial. Intended for laboratory models exploring combined angiogenic and actin-remodelling pathways. Supplied as lyophilized powder at ≥98% HPLC purity.
Use disclaimerFor Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Article reflects published preclinical and in-vitro literature. Additional citations available on request to research@peptitan.eu.